#Satpathy
Out today in @naturegenet.bsky.social -- PERFF-seq! With @tsionabay.bsky.social , @ronanchaligne.bsky.social, Bob Stickels, Meril Takizawa, + Ansu Satpathy, we describe this new assay to study rare populations with programmable nucleic acid cytometry. 1/n
www.nature.com/articles/s41...
Transcript-specific enrichment enables profiling of rare cell states via single-cell RNA sequencing - Nature Genetics
Programmable Enrichment via RNA FlowFISH by sequencing (PERFF-seq) isolates rare cells based on RNA marker transcripts for single-cell RNA sequencing profiling of complex tissues, with applicability t...
www.nature.com
January 8, 2025 at 1:30 PM
Now online in Cancer Discovery @aacrjournals.bsky.social: Integrative Proteogenomics & Forward Genetics Reveals a Novel Mitotic Vulnerability in TNBC - by Nicholas Neill, Shankha Satpathy, Trey Westbrook and colleagues doi.org/10.1158/2159... @bcmfromthelabs.bsky.social @broadinstitute.org
August 14, 2025 at 3:00 PM
Ansuman Satpathy will engineer T cell states with enhanced anti-cancer activity using synthetic transcription factors to modulate gene expression and advanced machine learning tools.
January 15, 2025 at 8:39 PM
#Monogram2026 Session 8 -
Regenerative, Precision, Profitable: Practices that Work

🍺 Christoph Dockter @carlsbergfondet.dk
📏 Stephen Pearce @rothamsted.bsky.social
🌾 Anisa Blower @niab-uk.bsky.social
🧬 Pooja Satpathy @leibnizipk.bsky.social
March 25, 2026 at 5:23 PM
They don’t dance together anymore but Surupa Sen and Bijayini Satpathy were 👌 in this:

www.youtube.com/watch?v=v7FM...
Ardhanarishwara by Nrityagram
YouTube video by NATARAJA dance group
www.youtube.com
January 11, 2026 at 6:54 PM
#MedSky🧪 #IDSky #Immunosky #publichealth Very interesting study Persistent antigen stimulation, as in cancer and chronic
infections, results in #Tcellexhaustion (TEX) a state of
impaired effector functions.
December 14, 2024 at 7:38 PM
Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in #Melanoma - by Sapir Cohen Shvefel, Joy Pai, Eytan Ruppin, Ansuman Satpathy, Yardena Samuels, and colleagues doi.org/10.1158/2159...
November 21, 2024 at 8:00 AM
I love when wonderful people are recognized for their great science!!! Congrats to great friends, colleagues and inspirations @marasherman.bsky.social and Ansu Satpathy (get on Bluesky, brother!) and congrats to all awardees!!
📢Announcing The Mark Foundation 2025 Emerging Leader Award winners! 📢

These 5 outstanding early-career scientists will receive a total of $3.75M to pursue projects with the potential to transform cancer research. We can’t wait to see what they achieve!
themarkfoundation.org/2025/01/the-...
January 17, 2025 at 1:56 PM
Exposure: Portrait Of A Corporate Crime
Documentation of the on-going tragedy following the explosion in 1984 of the Union Carbide's pesticide plant
📍Bhopal, India
📷Raghu Rai
#documentary #documentaryphotography #photography #monochrome #blackandwhite #bnw
www.magnumphotos.com/newsroom/exp...
June 22, 2026 at 5:10 AM
Thrilled to share our latest work in Cancer Cell! 🚨 Led by Chen Weller, Osnat Bartok, with amazing collaborators Chris Mcginnis, Ansuman Satpathy, Andreas Schlosser, Eytan Ruppin & more, we reveal that impaired translation fidelity enhances anti-tumor immunity!🧵(1/7)
March 30, 2025 at 7:08 AM
Single-cell profiling of innate and adaptive immune dysregulation in Long COVID

www.biorxiv.org/content/10.6...

Screenshot from latest Science for ME @scienceforme.bsky.social weekly update

#LongCovid
June 17, 2026 at 12:50 AM
What happens when the scientist becomes the subject?

Emerging Leader Award winner Ansuman Satpathy & collaborator Caleb Laureau are challenging conventional wisdom in genetics using findings from Satpathy’s own DNA.

themarkfoundation.org/blog/the-sci...
The Scientist Becomes the Subject: Ansuman Satpathy, MD, PhD | The Mark Foundation for Cancer Research
If you took a close look at your own DNA, what might you find? For 2025 Mark Foundation Emerging Leader Award winner Ansuman Satpathy, MD, PhD, the answer turned out to be a groundbreaking discovery.
themarkfoundation.org
December 10, 2025 at 7:36 PM
Smitha Radhakrishnan previews "Bijayini Satpathy in Rāgachitra": In her Boston solo premiere, "Rāgachitra," the celebrated Nrityagram artist draws on a lifetime in classical Indian dance to create searching, contemporary works shaped by memory and gender.

artsfuse.org/333184/dance...
August 24, 2026 at 12:03 PM
Last night, past Mark Foundation Emerging Leader Award winners gathered with this year’s recipients, @marasherman.bsky.social , @liron1bar-peled.bsky.social, Kai Kessenbrock, Ansu Satpathy, and Dan Wahl, to celebrate seven years of this transformational program. #MarkSymposium
April 3, 2025 at 1:02 PM
Excited to present our newest pre-print, “Bispecific T cell engagers control solid tumors through clonal replacement and IL2-driven effector differentiation of CD8 T cells.”

www.biorxiv.org/content/10.6...

Fantastic collaboration b/n the Satpathy, Sage, and Garcia labs at Stanford
December 8, 2025 at 3:06 PM
Vote for the SXSW 2027 session, "Can AI Cure Cancer? It Depends On The Data," with CRI’s Alicia Zhou, Stanford's Ansuman Satpathy, and 10x Genomics' Serge Saxonov, moderated by STAT's Angus Chen.
Voting closes soon: https://bit.ly/4q64R3w
August 17, 2026 at 8:37 PM
Inspiring work from the Satpathy Lab -- DESynR (Domain Engineered via Synthesis and Recombination) genes made through combinatorial assembly of TF family domains generate 'synthetic' T-cell states that outperform natural TF counterparts in tumor challenge models

www.biorxiv.org/content/10.1...
November 11, 2024 at 1:22 AM
Yasoda Satpathy graduated with her MD at just 21 years old 🩺⭐️

Dr. Satpathy graduated from high school at 14 years old, earned her undergraduate degree and began medical school at @ucsandiego.bsky.social 17 years old.

Now 21 years old, she will begin training at UCLA in internal medicine in July.
June 11, 2026 at 4:28 PM
Epigenetics Update - Synthetic transcription factors designed by domain recombination enhance CAR T cell antitumor function u.epigenome.us/ZgOvEtWH

Theodore L. Roth and Ansuman T. Satpathy (Stanford University) in Cell

#Epigenetics #CART #Cancer #TranscriptionFactors
---

epigenometech.com
August 25, 2026 at 4:36 PM
Vote for the SXSW 2027 session, "Can AI Cure Cancer? It Depends On The Data," with CRI’s Alicia Zhou, Stanford's Ansuman Satpathy, and 10x Genomics' Serge Saxonov, moderated by @statnews.com's Angus Chen.

Voting closes Aug 23: https://bit.ly/4q64R3w
August 10, 2026 at 9:58 PM
Single-cell profiling of innate and adaptive immune dysregulation in Long COVID — Satpathy et al

"Collectively, cellular communication analysis highlighted a reprogrammed immune signaling network in Long COVID, defined by selective crosstalk among monocytes, B cells, and NK cells."

#MECFS
Article Link
www.biorxiv.org
June 15, 2026 at 1:16 PM
WATCH: Bijayini Satpathy performs "ABHIPSAA — a Seeking" as part of Dancing the Gods, a festival of Indian dance presented in partnership with the World Music Institute. youtu.be/0JgsU8t1tZA?...
Dancing the Gods: Night Three featuring Bijayini Satpathy [Excerpt]
YouTube video by Asia Society
youtu.be
July 21, 2025 at 1:44 AM
Use BrowserStack App Automate with Appium UI Tests for .NET MAUI Apps | by Gerald Versluis & Sweeky Satpathy.

buff.ly/icnK8kD

#dotnetmaui #dotnet #testing #uitesting #automation #mobiledev
Use BrowserStack App Automate with Appium UI Tests for .NET MAUI Apps - .NET Blog
In this post, learn how to run your Appium UI Tests for .NET MAUI Apps on real devices on the cloud using BrowserStack App Automate.
buff.ly
March 27, 2025 at 6:00 PM
Synthetic transcription factors designed by domain recombination enhance CAR T cell antitumor function @cellcellpress.bsky.social
www.cell.com/cell/fulltex... @stanforduniversity.bsky.social #Roth #Satpathy
August 19, 2026 at 4:50 PM